Precision Peptide Company granted 600,000 restricted share units to a director and 1,100,000 stock options to directors, officers, and consultants, with options exercisable at $0.50 per share for three years. The company also settled $125,000 of debt owed to its CEO by issuing 300,000 common shares at a deemed price of $0.42 each. These moves are part of the company's incentive plan and debt management strategy, with shares issued subject to regulatory hold periods. This reflects ongoing efforts to align management incentives and manage liabilities as the company advances its peptide wellness products in North America.
Air Comm, a leading provider of wireless communication and security technology, has opened a new office in Farmers Branch, Texas, expanding its presence in the Dallas-Fort Worth area. This new location enhances Air Comm's ability to offer faster loca...
Metallium Limited has successfully operated three Flash Joule Heating units simultaneously at its Texas facility, marking a key milestone in scaling its proprietary technology. The operation achieved 83% availability and nearly 100% utilization, exce...
iRhythm Holdings disclosed a cybersecurity breach involving unauthorized access to data on third-party business applications. Hackers claimed to have sensitive company and patient information and demanded payment to avoid public release. The company ...
On June 15, 2026, BlackRock, Inc. and its funds reduced their total holdings in Orion Corporation to below 5% of the company's shares and voting rights. This change was disclosed under the Finnish Securities Market Act, indicating a decrease from a p...
BlackRock, Inc. has reported that its direct and indirect ownership in Orion Oyj has dropped below the 5% threshold as of June 15, 2026. This change requires a formal disclosure under Finnish securities law. The reduction in BlackRock's stake may aff...
